Most Expedited Reviews For Generic HIV Drugs Are For Single Agents – FDA
Executive Summary
FDA is expanding its program to expedite the review of fixed-dose combination and co-packaged HIV drugs to include single-ingredient copies of certain antiretroviral drugs, according to a recently released final guidance